However, the glucose-restrictive environment caused by rapidly proliferating tumor cells can metabolically block T cells, reducing IFN-γ production and leading to decreased proinflammatory cytokines and T cell hyporesponsiveness over time [80]. Here, IFNG is linked to neoplasm.